Takotsubo Cardiomyopathy Clinical Trials

13 recruiting

Takotsubo Cardiomyopathy Trials at a Glance

13 actively recruiting trials for takotsubo cardiomyopathy are listed on ClinicalTrialsFinder across 6 cities in 8 countries. The largest study group is Not Applicable with 5 trials, with the heaviest enrollment activity in New York, Bad Nauheim, and Bad Tatzmannsdorf. Lead sponsors running takotsubo cardiomyopathy studies include University of Aberdeen, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, and Cedars-Sinai Medical Center.

Browse takotsubo cardiomyopathy trials by phase

Treatments under study

About Takotsubo Cardiomyopathy Clinical Trials

Looking for clinical trials for Takotsubo Cardiomyopathy? There are currently 13 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Takotsubo Cardiomyopathy trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Takotsubo Cardiomyopathy clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 113 of 13 trials

Recruiting
Not Applicable

Is There a Genetic Predisposition for Acute Stress-induced (Takotsubo) Cardiomyopathy

Takotsubo Cardiomyopathy
University of Aberdeen700 enrolled2 locationsNCT04513054
Recruiting
Phase 2

Cyclosporine In Takotsubo Syndrome

Takotsubo Cardiomyopathy
University Hospital Heidelberg204 enrolled24 locationsNCT05946772
Recruiting
Not Applicable

Manganese-enhanced Magnetic Resonance Imaging in Takotsubo Cardiomyopathy

Takotsubo Cardiomyopathy
University of Edinburgh100 enrolled1 locationNCT07491718
Recruiting

Registry of Patients With Takotsubo Syndrome

Takotsubo CardiomyopathyBroken Heart Syndrome
NYU Langone Health500 enrolled1 locationNCT03663348
Recruiting

The Cedars-Sinai Smidt Heart Institute Takotsubo Registry & Proteomic Study

Takotsubo Cardiomyopathy
Cedars-Sinai Medical Center1,000 enrolled1 locationNCT03910569
Recruiting
Not Applicable

Psychosocial Support for Patients With Takotsubo Syndrome

Takotsubo Cardiomyopathy
Weill Medical College of Cornell University24 enrolled1 locationNCT05977049
Recruiting

Prognotic Role of CMR in Takotsubo Syndrome

Magnetic Resonance ImagingMachine LearningTakotsubo Cardiomyopathy
University of Cagliari350 enrolled1 locationNCT06277297
Recruiting

Cardiac Assessment and Takotsubo-stunning Among COPD-exacerbations In-Hospital

Chronic Obstructive Pulmonary DiseaseAcute Heart FailureTakotsubo Cardiomyopathy
Sahlgrenska University Hospital200 enrolled1 locationNCT06597331
Recruiting

Establishing the Incidence of Tako-tsubo Cardiomyopathy in Scotland

Myocardial InfarctionTakotsubo Cardiomyopathy
University of Aberdeen800 enrolled1 locationNCT03299569
Recruiting
Not Applicable

Effectiveness of a Resilience-Based Rehabilitation Program for Patients with Coronary Heart Disease

Acute Coronary SyndromeTakotsubo Cardiomyopathy
Pensionsversicherungsanstalt130 enrolled1 locationNCT06332859
Recruiting

Characterization of Acute Myocardial Damage With Spectral Computed Tomography. (CADAMI-SPECTRAL)

Myocardial InjuryTakotsubo CardiomyopathyMyocarditis; Acute or Subacute+1 more
Salamanca University Hospital300 enrolled1 locationNCT06506071
Recruiting
Not Applicable

Characterization of priMary And sEcondary STress Related takOtsubo

Takotsubo CardiomyopathySepsis-induced Cardiomyopathy
Fondazione Policlinico Universitario Agostino Gemelli IRCCS60 enrolled1 locationNCT05793008
Recruiting
Phase 2

Can use of N-acetylcysteine and Ramipril improve clinical outcomes in Tako Tsubo Cardiomyopathy (TTC) patients? A randomised controlled trial.

Takotsubo Cardiomyopathy
Cardiology Department, Queen Elizabeth Hospital100 enrolled3 locationsACTRN12616000781448